Samarth Kulkarni Crispr Therapeutics Ag (CRSP) insider trading activity

Samarth Kulkarni is Chief Executive Officer of CRISPR Therapeutics AG. Currently has a direct ownership of 254,201 shares of CRSP, which is worth approximately $14.3 Million. The most recent transaction as insider was on Jun 01, 2020, when has been sold 17,275 shares (Common Shares) at a price of $1.81 per share, resulting in proceeds of $31,268. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 254K

30.3% 3M change

12.21% 12M change

Total Value Held $14.3 Million

Samarth Kulkarni Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 01 2020	BUY Exercise of conversion of derivative security	$31,268 $1.81 p/Share	17,275 Added 8.38%	188,801 Common Shares
May 20 2020	SELL Open market or private sale	$698,039 $65.28 p/Share	10,693 Reduced 5.87%	171,526 Common Shares
May 20 2020	BUY Exercise of conversion of derivative security	$19,354 $1.81 p/Share	10,693 Added 5.54%	182,219 Common Shares
May 19 2020	SELL Open market or private sale	$280,644 $65.16 p/Share	4,307 Reduced 2.45%	171,526 Common Shares
May 19 2020	BUY Exercise of conversion of derivative security	$7,796 $1.81 p/Share	4,307 Added 2.39%	175,833 Common Shares
Mar 02 2020	SELL Payment of exercise price or tax liability	$41,876 $52.74 p/Share	794 Reduced 0.46%	171,526 Common Shares
Dec 16 2019	BUY Exercise of conversion of derivative security	$14,480 $1.81 p/Share	8,000 Added 4.44%	172,320 Common Shares
Dec 01 2019	SELL Payment of exercise price or tax liability	$53,093 $71.65 p/Share	741 Reduced 0.45%	164,320 Common Shares
Sep 01 2019	SELL Payment of exercise price or tax liability	$34,195 $46.21 p/Share	740 Reduced 0.45%	165,061 Common Shares
Jun 17 2019	SELL Open market or private sale	$920,000 $46.0 p/Share	20,000 Reduced 10.76%	165,801 Common Shares
Jun 17 2019	BUY Exercise of conversion of derivative security	$36,200 $1.81 p/Share	20,000 Added 9.72%	185,801 Common Shares
Jun 01 2019	SELL Payment of exercise price or tax liability	$26,357 $35.57 p/Share	741 Reduced 0.44%	165,801 Common Shares
Apr 29 2019	SELL Open market or private sale	$840,600 $42.03 p/Share	20,000 Reduced 10.72%	166,542 Common Shares
Apr 29 2019	BUY Exercise of conversion of derivative security	$36,200 $1.81 p/Share	20,000 Added 9.68%	186,542 Common Shares
Mar 01 2019	SELL Payment of exercise price or tax liability	$29,898 $39.97 p/Share	748 Reduced 0.45%	166,542 Common Shares
Dec 07 2018	BUY Exercise of conversion of derivative security	$38,915 $1.81 p/Share	21,500 Added 11.39%	167,290 Common Shares
Dec 01 2018	SELL Payment of exercise price or tax liability	$28,403 $38.33 p/Share	741 Reduced 0.51%	145,790 Common Shares
Sep 01 2018	SELL Payment of exercise price or tax liability	$41,992 $56.67 p/Share	741 Reduced 0.5%	146,531 Common Shares
Jun 04 2018	SELL Payment of exercise price or tax liability	$49,743 $67.13 p/Share	741 Reduced 0.5%	147,819 Common Shares
Jun 01 2018	SELL Open market or private sale	$1,031,700 $68.78 p/Share	15,000 Reduced 9.17%	148,560 Common Shares
Jun 01 2018	BUY Exercise of conversion of derivative security	$27,150 $1.81 p/Share	15,000 Added 8.4%	163,560 Common Shares
Dec 21 2017	BUY Exercise of conversion of derivative security	$27,150 $1.81 p/Share	15,000 Added 9.17%	148,560 Common Shares
Dec 01 2017	BUY Grant, award, or other acquisition	$509,873 $19.12 p/Share	26,667 Added 16.64%	133,560 Restricted Stock Units
Aug 30 2017	SELL Open market or private sale	$80,000 $20.0 p/Share	4,000 Reduced 3.61%	106,893 Common Shares
Aug 28 2017	SELL Open market or private sale	$465,164 $20.09 p/Share	23,154 Reduced 17.27%	110,893 Common Shares

Also insider at

BDTX

Black Diamond Therapeutics, Inc. Healthcare

RPTX

Repare Therapeutics Inc. Healthcare

CNTA

Centessa Pharmaceuticals plc Healthcare

Director

ABIO

ARCA biopharma, Inc. Healthcare

Director